Application of tacrolimus in the treatment of skin diseases other than atopic dermatitis

In dermatological therapy, a basic group of drugs with immunosuppressive and anti-inflammatory effects is the glucocorticoids. Their mechanism of action may lead to numerous side effects. The discovery of cyclosporin A, tacrolimus and pimecrolimus has created an alternative to steroid therapy in dermatology. A common feature of calcineurin inhibitors is inhibition of the activity of immunocompetent cells, which are responsible for inflammatory processes in the human body. Most studies on this group of drugs concern their effectiveness in the treatment of atopic dermatitis (AD). This paper presents a review of the literature concerning the use of tacrolimus in therapy of diseases other than AD.

[1]  J. Q. Rosso,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions , 2012 .

[2]  T. Luger,et al.  Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. , 2011, Journal of the American Academy of Dermatology.

[3]  Susun Bellew,et al.  Topical treatment of perianal eczema with tacrolimus 0·1% , 2011 .

[4]  R. Tsuboi,et al.  Rosaceiform dermatitis associated with topical tacrolimus treatment. , 2010, Journal of the American Academy of Dermatology.

[5]  S. Reitamo,et al.  Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: Results from two randomized, multicentre, comparative studies , 2010, The Journal of dermatological treatment.

[6]  J. Narbutt,et al.  Wyprysk opryszczkowaty Kaposiego u dziecka z atopowym zapaleniem skóry w trakcie leczenia pimekrolimusem (1% krem) , 2010 .

[7]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. , 2009, Journal of the American Academy of Dermatology.

[8]  A. Morrone,et al.  Topical tacrolimus treatment for localized pretibial bullous phemphigoid , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  A. Samdani,et al.  COMPARISON OF EFFECTIVENESS OF TOPICAL TACROLIMUS AND BETAMETHASONE WITH SOFT PARAFFIN IN THE TREATMENT OF PATCHY ALOPECIA AREATA , 2009 .

[10]  S. Agrawal,et al.  Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone , 2009, Clinical Rheumatology.

[11]  P. Elsner,et al.  Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis , 2008, Contact dermatitis.

[12]  Cheryl Bansal,et al.  Chronic cutaneous lupus in childhood: a report of two cases and review of the literature , 2008, International journal of dermatology.

[13]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. , 2008, Journal of the American Academy of Dermatology.

[14]  Y. Liao,et al.  Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g−1 ointment and tacrolimus 0·3 mg g−1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double‐blind, randomized controlled trial , 2007, The British journal of dermatology.

[15]  A. Paller,et al.  Tacrolimus Ointment is Effective for Psoriasis on the Face and Intertriginous Areas in Pediatric Patients , 2007, Pediatric dermatology.

[16]  M. Corazza,et al.  Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. , 2007, Acta dermato-venereologica.

[17]  N. Sakakibara,et al.  Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus , 2006, The Journal of dermatology.

[18]  T. Luger,et al.  Treatment of pruritic diseases with topical calcineurin inhibitors , 2006, Therapeutics and clinical risk management.

[19]  M. Regaña,et al.  Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. , 2006 .

[20]  H. Hönigsmann,et al.  Review of the potential photo‐cocarcinogenicity of topical calcineurin inhibitors , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  G. Mancuso,et al.  Localized scleroderma: response to occlusive treatment with tacrolimus ointment , 2005, The British journal of dermatology.

[22]  J. Dissemond,et al.  Successful treatment of stasis dermatitis with topical tacrolimus. , 2004, VASA. Zeitschrift fur Gefasskrankheiten.

[23]  Pille Harrison,et al.  Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. , 2004, Rheumatology.

[24]  M. Lebwohl,et al.  Tacrolimus ointment is effective for facial and intertriginous psoriasis. , 2004, Journal of the American Academy of Dermatology.

[25]  J. Saurat,et al.  Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. , 2004, Archives of dermatology.

[26]  M. Meurer,et al.  Topical tacrolimus treatment for cicatricial pemphigoid. , 2004, Journal of the American Academy of Dermatology.

[27]  R. Phelps,et al.  Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo: A Pilot Study , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[28]  B. Elliott,et al.  Tacrolimus effect on rosacea. , 2004, Journal of the American Academy of Dermatology.

[29]  T. Luger,et al.  Topical Tacrolimus as a Therapeutic Adjunct in Patients with Cutaneous Lupus erythematosus , 2004, Dermatology.

[30]  G. Mancuso,et al.  Topical tacrolimus in the treatment of localized scleroderma. , 2003, European journal of dermatology : EJD.

[31]  N. Korman,et al.  The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. , 2003, Archives of dermatology.

[32]  R. Laws,et al.  Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea. , 2003, Cutis.

[33]  T. Liesegang,et al.  Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. , 2003, Archives of dermatology.

[34]  G. Weinstein,et al.  An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[35]  S. Soon,et al.  Tacrolimus 0·1% ointment for seborrhoeic dermatitis: an open‐label pilot study , 2003, The British journal of dermatology.

[36]  N. Silverberg,et al.  Successful treatment of vitiligo with 0.1% tacrolimus ointment. , 2003, Archives of dermatology.

[37]  B. Moncada,et al.  A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. , 2003, Archives of Dermatology.

[38]  L. Borradori,et al.  Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus , 2003, The British journal of dermatology.

[39]  M. Lebwohl,et al.  Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. , 2003, Journal of the American Academy of Dermatology.

[40]  K. Watsky.  Erosive perianal lichen planus responsive to tacrolimus , 2003, International journal of dermatology.

[41]  E. Tanghetti.  Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. , 2003, Cutis.

[42]  B. Moncada,et al.  Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet‐B–narrow‐band , 2003, Photodermatology, photoimmunology & photomedicine.

[43]  A. Wollenberg,et al.  Is topical tacrolimus effective in alopecia areata universalis? , 2002, The British journal of dermatology.

[44]  P. Grimes,et al.  Topical tacrolimus for repigmentation of vitiligo. , 2002, Journal of the American Academy of Dermatology.

[45]  J. Hanifin,et al.  Repigmentation of Vitiligo with Topical Tacrolimus , 2002, Dermatology.

[46]  A. Fleischer,et al.  Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. , 2002, Journal of the American Academy of Dermatology.

[47]  G. Kirtschig,et al.  Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus , 2002, The British journal of dermatology.

[48]  M. Pittelkow,et al.  Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. , 2002, Journal of the American Academy of Dermatology.

[49]  J. Lewsey,et al.  Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. , 2002, Journal of the American Academy of Dermatology.

[50]  A. Paller,et al.  A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. , 2001, Journal of the American Academy of Dermatology.

[51]  Sewon Kang,et al.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. , 2001, Journal of the American Academy of Dermatology.

[52]  M. Lahfa,et al.  Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis , 2000 .

[53]  B. Thiers.  Topical tacrolimus: treatment failure in a patient with alopecia areata. , 2000, Archives of dermatology.

[54]  A. Remitz,et al.  Tacrolimus ointment improves psoriasis in a microplaque assay , 1999, The British journal of dermatology.

[55]  Vente,et al.  Erosive mucosal lichen planus: response to topical treatment with tacrolimus , 1999, The British journal of dermatology.

[56]  M. Rudin,et al.  Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. , 1999, The Journal of pharmacology and experimental therapeutics.

[57]  M. Boguniewicz,et al.  A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. , 1998, The Journal of allergy and clinical immunology.

[58]  Vente,et al.  Topical tacrolimus for pyoderma gangrenosum , 1998, The British journal of dermatology.

[59]  L. Dubertret,et al.  Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. , 1998, Archives of dermatology.

[60]  H. Nakagawa,et al.  Tacrolimus Has Antifungal Activities against Malassezia furfur Isolated from Healthy Adults and Patients with Atopic Dermatitis , 1996 .

[61]  E. Farmer,et al.  Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. , 1996, Journal of the American Academy of Dermatology.

[62]  A. Thomson,et al.  Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy. , 1995, Transplantation.

[63]  H. Nakagawa,et al.  Tacrolimus ointment for atopic dermatitis , 1994, The Lancet.

[64]  D. V. van Thiel,et al.  Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. , 1991, Transplantation proceedings.

[65]  M. Okuhara,et al.  FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. , 1987, The Journal of antibiotics.

[66]  M. Okuhara,et al.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. , 1987, The Journal of antibiotics.